期刊文献+

汉族人载脂蛋白A5基因-1131T>C多态性与2型糖尿病合并冠心病的相关性研究 被引量:1

Relationship between Apolipoprotein AV gene-1131T>C polymorphism and Type 2 Diabetes Mellitus with Coronary Heart Disease in Han Nationality
下载PDF
导出
摘要 目的探讨我国北方地区汉族人载脂蛋白A5基因(APOA5)-1131T>C多态性对血脂的影响及其与2型糖尿病合并冠心病的关系。方法应用聚合酶链反应限制性片段长度多态性(PCR-RFLP)技术检测了136例健康对照者、163例2型糖尿病患者(DM组)和114例经冠状动脉造影确诊的2型糖尿病合并冠心病患者(DM+CHD组)APOA5-1131T>C多态性基因型和等位基因频率分布,同时检测了研究对象的血脂、脂蛋白和载脂蛋白水平。结果健康对照组APOA5-1131T>C多态性与血清甘油三酯(TG)水平密切相关,C等位基因携带者TG水平明显高于TT基因型(1.38比0.91mmol/L,P<0.001)。2型糖尿病合并冠心病组APOA5-1131C等位基因频率明显高于对照组(38.4%比28.3%,P=0.023),TT、TC、CC基因型频率在DM+CHD组和对照组分别为33.9%、55.4%、10.7%和50.4%、42.5%、7.1%,两组间差异具有统计学意义(P<0.05)。而2型糖尿病组和对照组相比,APOA5-1131T>C多态性基因型频率和等位基因频率分布均无差异。结论APOA5- 1131T>C多态性对人群TG水平有极显著影响,C等位基因与2型糖尿病合并冠心病的患病风险有一定关系。 Objective To investigate the influence of APOAS-1131T 〉 C polymorphism on plasma lipids and the susceptibility to coronary artery disease (CHD) in type 2 diabetics in Han nationality. Methods The genotypes of APOAS-1131T 〉 C polymorphism were analyzed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) in 136 control subjects, 163 type 2 diabetics and 114 type 2 diabetes mellitus (DM) with CHD patients. Results The frequency of APOAV -1131 C allele in DM + CHD group was significantly higher than that of the subjects in the control group (38.4% vs. 28.3% , P =0.023 ). The distributions of the APOAS-1131T 〉 C genotypes (T/T, T/C and C/C ) were 33.9%, 55.4% and 10.7% in DM + CHD cases and 50.4% , 42.5% and 7.1% in the controls, respectively (P 〈 0.05 ). Frequencies of alleles and genotypes in type 2 diabetics were not significant compared to that of the controls. In the controls, serum TG level in the subjects with the TF genotype was significantly lower than that in those with TC and CC (0.91 vs. 1.38retool/L, P 〈 0. 001 ). Conclusion The genetic effects of APOAS-1131T 〉 C polymorphism on serum TG concentration are confirmed in Chinese population, this polymorphism might play a role in elevated plasma TG levels in type 2 diabetic patients.
出处 《中国分子心脏病学杂志》 CAS 2007年第4期189-194,共6页 Molecular Cardiology of China
关键词 载脂蛋白A5 基因多态性 甘油三酯 冠状动脉粥样硬化性心脏病 糖尿病 Apolipoprotein A5 polymorphism triglyceride coronary artery disease type 2 diabetes mellitus
  • 相关文献

参考文献15

  • 1毕楠,鄢盛恺,李国平,尹志农,薛红,吴刚,陈保生.冠心病患者载脂蛋白A5和载脂蛋白C3基因多态性的研究[J].中华心血管病杂志,2005,33(2):116-121. 被引量:47
  • 2鄢盛恺,周新,哈黛文.聚合酶链反应限制性片段长度多态性检测载脂蛋白E基因型[J].中华医学检验杂志,1997,20(1):28-31. 被引量:60
  • 3[3]Pennacchio LA,Olivier M,Hubacek JA,et al.An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.Science,2001,294:169-173.
  • 4[4]Van der Vliet HN,Sammels MG,Leegwater AC,et al.Apolipoprotein A-V:a novel apolipoprotein associated with an early phase of liver regeneration.J Biol Chem,2001,276:44512-44520.
  • 5[5]Baum L,Tomlinson B,Thomas GN.APOA5-1131T > C polymorphism is associated with triglyceride levels in Chinese men.Clin Genet,2003,63:377-379.
  • 6[6]Lai CQ,Tai ES,Tan CE,et al.The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore.J Lipid Res,2003,44:2365-2373.
  • 7[7]Nabika T,Nasreen S,Kobayashi S,et al.The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese.Atherosclerosis,2002,165:201-204.
  • 8[8]Endo K,Yanagi H,Araki J,et al.Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren.Hum Genet,2002,111:570-572.
  • 9[9]Jang Y,Kim JY,Kim OY,et al.The -1131T->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small,dense LDL concentrations; and oxidative stress in nonobese Korean men.Am J Clin Nutr,2004,80:832-840.
  • 10[10]Horinek A,Vrablik M,Ceska R,et al.T-1131-> C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals.Atherosclerosis,2003,167:369-370.

二级参考文献16

  • 1鄢盛恺,周新,哈黛文.聚合酶链反应限制性片段长度多态性检测载脂蛋白E基因型[J].中华医学检验杂志,1997,20(1):28-31. 被引量:60
  • 2Zemel PC, Sowers JR. Relation between lipids and atherosclerosis: epidemiologic evidence and clinical implications. Am J Cardiol, 1990,66:7I-12I.
  • 3Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science, 2001,294:169-173.
  • 4Szalai C, Keszai M, Duba J, et al. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis, 2004,173: 109-114.
  • 5Thompson EA, Deeb S, Walker D, et al. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet, 1988,42:113-124.
  • 6Pennacchio LA, Olivier M, Hubacek JA, et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet, 2002,11:3031-3038.
  • 7Endo K, Yanagi H, Araki J, et al. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and serum triglyceride level in Japanese schoolchildren. Hum Genet, 2002, 111:570-572.
  • 8Lai CQ, Tai ES, Tan CE, et al. The apolipoprotein A5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res, 2003,44:2365-2373.
  • 9Kao JT, Wen HC, Chien KL, et al. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet, 2003,12:2533-2539.
  • 10Anthony J. Brookes. The essence of SNPs. Gene, 1999,234:177-186.

共引文献104

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部